Novo Nordisk A/S – share repurchase programme

Bagsværd, Denmark, 27 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Rules”). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.

Under the programme initiated 4 February 2026, Novo Nordisk will repurchase B shares for an amount up to DKK 3.8 billion in the period from 4 February 2026 to 4 May 2026.

Since the announcement 20 April 2026, the following transactions have been made:

  Number of
B shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement 12,257,992   3,148,710,807
20 April 2026 230,000 255.92 58,861,892
21 April 2026 230,000 255.95 58,868,391
22 April 2026 230,000 249.65 57,420,415
23 April 2026 230,000 249.19 57,313,744
24 April 2026 230,000 251.11 57,755,946
Accumulated under the programme 13,407,992   3,438,931,195

The details for each transaction made under the share repurchase programme are published on novonordisk.com.

With the transactions stated above, Novo Nordisk owns a total of 30,797,791 B shares of DKK 0.10 as treasury shares, corresponding to 0.7% of the share capital. The total amount of A and B shares in the company is 4,465,000,000 including treasury shares.

Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 4 February 2026. As of 24 April 2026, Novo Nordisk has since 4 February 2026 repurchased a total 13,407,992 B shares at an average share price of DKK 256.48 per B share equal to a transaction value of DKK 3,438,931,195.

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries. Novo Nordisk’s B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com,Facebook, Instagram, X, LinkedIn andYouTube.

Contacts for further information

Media:  
Ambre James-Brown
+45 3079 9289
globalmedia@novonordisk.com
Liz Skrbkova (US)
+1 609 917 0632
lzsk@novonordisk.com
Investors:  
Michael Novod
+45 3075 6050
nvno@novonordisk.com
Jacob Martin Wiborg Rode
+45 3075 5956
jrde@novonordisk.com
Max Ung
+45 3077 6414
mxun@novonordisk.com
Sina Meyer
+45 3079 6656
azey@novonordisk.com
Alex Bruce
+45 34 44 26 13
axeu@novonordisk.com
Christoffer Sho Togo Tullin
+45 3079 1471
cftu@novonordisk.com
Frederik Taylor Pitter
+1 609 613 0568
fptr@novonordisk.com
Mads Berner Bruun
+45 3075 2936
mbbz@novonordisk.com

Company announcement No 28

  • CA20260427_Safe Harbour

  • 20260427_safe harbour transaction details


Source link

Visited 1 times, 1 visit(s) today

Related Article

The Federal Reserve’s April Inflation Forecast Has Been Updated, and It’s a Good News-Bad News Scenario for Wall Street

Last week was another history-maker for Wall Street, with the benchmark S&P 500 (SNPINDEX: ^GSPC) and iconic Nasdaq Composite (NASDAQINDEX: ^IXIC) launching to record-closing highs. Although the Dow Jones Industrial Average (DJINDICES: ^DJI) didn’t reach a record high, it’s a stone’s throw away from one. Based on the performance of these indexes, you’d assume the

The SpaceX IPO Timeline: Every Important Date and Time Frame You Need to Know

The S&P 500 (^GSPC +0.80%) and Nasdaq Composite (^IXIC +1.63%) aren’t the only things making history on Wall Street. Shortly, we’ll be witnessing the largest-ever initial public offering (IPO), courtesy of Elon Musk’s SpaceX. While several prominent private artificial intelligence superstars are expected to go public toward the end of this year, including OpenAI and

April 2026’s UK Stocks That May Be Trading Below Estimated Value

As the FTSE 100 and FTSE 250 indices experience downward pressure due to weak trade data from China and declining commodity prices, investors in the United Kingdom are closely monitoring market conditions for opportunities. In such an environment, identifying stocks that may be trading below their estimated value can offer potential benefits, as these investments

If a stock market crash is coming, this is the FTSE shares I want to buy

Image source: Getty Images Whether we’re talking about an impending stock market crash or something less dramatic, it’s clear some of us feel that share prices are looking a bit frothy. Last week, Sarah Breeden, deputy governor for the Bank of England (BoE), said the quiet part out loud: “There’s a lot of risk out

Pareto Securities cuts Cellavision price target to SEK 140 (200), reiterates Buy

Market Closed – Nasdaq Stockholm 12:00:00 2026-04-24 pm EDT 5-day change 1st Jan Change 120.20 SEK -21.54% -25.62% -23.54% Published on 04/27/2026 at 12:13 am EDT Finwire – Translated by Marketscreener Legal disclaimer Contact us to request a correction – See original Pareto Securities lowers its price target for Cellavision to SEK 140 (200) while

Undiscovered Gems in Middle East Stocks for April 2026

As Middle Eastern stock markets experience modest gains despite geopolitical tensions and economic challenges, investors are keenly observing the region’s small-cap companies for potential opportunities. In this environment, identifying stocks with strong fundamentals and resilience to external pressures can be crucial for navigating the complexities of the current market landscape. Name Debt To Equity Revenue

Sumitomo Pharma Co Ltd – Notice regarding withdrawal of shelf registration statement for issuance of new shares

Delayed Japan Exchange 10:30:00 2026-04-26 pm EDT 5-day change 1st Jan Change 1,950.50 JPY -5.36% -5.91% -15.85% Published on 04/26/2026 at 10:41 pm EDT Reuters © Reuters – 2026 DurationAuto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax. PeriodDayWeek Sumitomo Pharma Co Ltd, formerly Sumitomo Dainippon Pharma Co Ltd, is a Japan-based pharmaceutical company. The

Broadcom Joins the $2 Trillion Club, and 4 of the 5 Vanguard ETFs That Just Underwent Stock Splits Hold It. Here’s an Even Better Low-Cost ETF for Long-Term Broadcom Investors.

Five low-cost exchange-traded funds (ETFs) operated by investment management firm Vanguard underwent stock splits on April 21. And Broadcom (AVGO +0.62%) is a top 10 holding in four of those five funds. The next day, on April 22, Broadcom hit an all-time high amid a broader stock market rally and Alphabet-related news. Broadcom is expanding

Graco (GGG) Valuation Check After Recent Share Price Moves

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE. Graco (GGG) has been drawing attention after recent share price moves, with the stock closing at US$81.58 as investors weigh its performance in contractor, industrial, and expansion market segments. See our latest analysis for Graco. Recent

Earnings Calendar for the Week: A Star-Studded Lineup on the Markets

Welcome to the corporate earnings calendar for the week of April 27 to May 1, 2026. The highlights this week include results from Microsoft, Exxon Mobil, LVMH, Alphabet, TotalEnergies, Airbus, Meta Platforms, BNP Paribas, Novartis and Samsung Electronics. Monday, April 27, 2026 US & Canada Verizon Communications, Inc.: Earnings Public Storage: Earnings Nucor Corporation: Earnings

ASX Growth Leaders With High Insider Ownership April 2026

As the Australian share market shows resilience with a +0.4% advance amidst global uncertainties, particularly contrasting Wall Street’s downturn, investors are keenly observing how local factors such as potential interest rate changes influence trading sentiment. In this environment, companies with high insider ownership often attract attention for their perceived alignment of interests between management and

Low Volatility Meets High Dividend Yield

Bristol Myers Squibb (NYSE: BMY) has been on a decent run over the past year, with the stock price climbing more than 20%. That may be surprising to some, as the company expects lower sales in 2026 than in 2025. On the surface, that does sound like enough to keep some investors away. Will AI

“Sounds Interesting, But Not 100% Up Interesting, Sell Some”

POET Technologies Inc. (NASDAQ:POET) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Noting the stock’s parabolic move, Cramer said: Then there’s POET, Navitas, and Credo. These are all semiconductor networking stocks that have gone parabolic, each up around 100% this month. We profiled POET earlier

Is Equinix, Inc. (EQIX) A Good Stock To Buy Now?

Is EQIX a good stock to buy? We came across a bullish thesis on Equinix, Inc. on r/AIPortfolios by manojs. In this article, we will summarize the bulls’ thesis on EQIX. Equinix, Inc.’s share was trading at $1,103.97 as of April 20th. EQIX’s trailing and forward P/E were 80.23 and 67.11 respectively according to Yahoo Finance. Is

Apple after Cook, Allbirds after shoes, and TKer Stock Market Truth No. 9 🍎🐦

Nothing lasts forever. This is especially true in the business world: Entrepreneurs and executives come and go, and industries and companies rise and fall. These dynamics are very much at the core of TKer Stock Market Truth No. 9: There’s a lot of turnover in the stock market. Specifically, this observation concerns how stocks are

0
Would love your thoughts, please comment.x
()
x